Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Bone metabolism markers and ghrelin in boys at different stages of sexual maturity.

Jürimäe J, Pomerants T, Tillmann V, Jürimäe T.

Acta Paediatr. 2009 May;98(5):892-6. doi: 10.1111/j.1651-2227.2008.01193.x.

PMID:
19243352
2.

Guidelines for the management of growth failure in childhood inflammatory bowel disease.

Heuschkel R, Salvestrini C, Beattie RM, Hildebrand H, Walters T, Griffiths A.

Inflamm Bowel Dis. 2008 Jun;14(6):839-49. doi: 10.1002/ibd.20378.

PMID:
18266237
3.

Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease.

Nissel R, Lindberg A, Mehls O, Haffner D; Pfizer International Growth Database (KIGS) International Board..

J Clin Endocrinol Metab. 2008 Apr;93(4):1359-65. doi: 10.1210/jc.2007-2302.

PMID:
18198222
4.

Chronic pediatric inflammatory diseases: effects on bone.

Viswanathan A, Sylvester FA.

Rev Endocr Metab Disord. 2008 Jun;9(2):107-22. doi: 10.1007/s11154-007-9070-0. Review.

PMID:
18165904
5.

Bone status in juvenile systemic lupus erythematosus.

Lilleby V.

Lupus. 2007;16(8):580-6. Review.

PMID:
17711892
6.

Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.

Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, Doria AS, Stephens D, Gilday D, Silverman ED.

Arthritis Rheum. 2007 Jun;56(6):1966-73.

7.

Osteoporosis in juvenile idiopathic arthritis--a practical approach to diagnosis and therapy.

Roth J, Bechtold S, Borte G, Dressler F, Girschick HJ, Borte M.

Eur J Pediatr. 2007 Aug;166(8):775-84. Review.

PMID:
17436015
8.

Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease.

Zemel BS, Kawchak DA, Ohene-Frempong K, Schall JI, Stallings VA.

Pediatr Res. 2007 May;61(5 Pt 1):607-13.

PMID:
17413865
9.

Bone mass, biochemical markers and growth in children with chronic kidney disease: a 1-year prospective study.

Swolin-Eide D, Magnusson P, Hansson S.

Acta Paediatr. 2007 May;96(5):720-5.

PMID:
17381473
10.

The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis.

Cahue S, Sharma L, Dunlop D, Ionescu M, Song J, Lobanok T, King L, Poole AR.

Osteoarthritis Cartilage. 2007 Jul;15(7):819-23.

11.

Glucocorticoid-induced osteoporosis in children: impact of the underlying disease.

Leonard MB.

Pediatrics. 2007 Mar;119 Suppl 2:S166-74. Review.

PMID:
17332238
12.

The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race.

Kalkwarf HJ, Zemel BS, Gilsanz V, Lappe JM, Horlick M, Oberfield S, Mahboubi S, Fan B, Frederick MM, Winer K, Shepherd JA.

J Clin Endocrinol Metab. 2007 Jun;92(6):2087-99.

PMID:
17311856
13.

Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis.

Mazzuca SA, Poole AR, Brandt KD, Katz BP, Lane KA, Lobanok T.

J Rheumatol. 2006 Jun;33(6):1147-51.

PMID:
16652436
14.

Interplay between interferon and other cytokine systems in bone metabolism.

Takayanagi H, Sato K, Takaoka A, Taniguchi T.

Immunol Rev. 2005 Dec;208:181-93. Review.

PMID:
16313349
15.
16.

Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.

Coelho LF, Magno de Freitas Almeida G, Mennechet FJ, Blangy A, Uzé G.

Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11917-22.

17.

Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus.

Lilleby V, Lien G, Frey Frøslie K, Haugen M, Flatø B, Førre Ø.

Arthritis Rheum. 2005 Jul;52(7):2051-9.

18.

Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.

Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE.

Arthritis Rheum. 2005 Jul;52(7):2044-50.

20.

Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.

Chen CJ, Chao TY, Janckila AJ, Cheng SN, Ku CH, Chu DM.

J Pediatr Endocrinol Metab. 2005 Jan;18(1):55-62.

PMID:
15679069
Items per page

Supplemental Content

Support Center